Roy: Yellowdig conducted over 12 studies to validate product efficacy
Shaunak Roy · Edtech SaaS Breaks $4m, Looking at $10m Series B Next · Feb 19, 2022 · at 9:21
Shanak Roy is the founder and CEO of Yellowdig. He explains why edtech requires rigorous efficacy testing prior to scaling.
0:00 / 0:08exact quote · 8.5s
720p mp4 · rendered on demand · StarZero watermark
“So we have done over 12 studies with our variety of partners and third parties to prove the value of the product before we could scale the technology.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Shaunak Roy
Edtech startups face massive upfront compliance investments before selling early licenses
“Even if you want to sell like five pieces of license for school, you have to be compliant in all of them. Otherwise you can't sell. So there are significant investments that are needed to be able to comply with those regulations in terms of product processes a…”
Yellowdig partners with Barnes & Noble for nationwide university distribution
“We are a bonds and rebels partner. So we are pretty much in all over the country.”
Direct-to-consumer sales represent roughly 20% of Yellowdig's total revenue
“Direct to consumer is a new business model for us. We launched it in the beginning of 2020. So that's a segment which is growing for us right now. We expect that to grow rapidly in this year. But right now I would say it's about 20% of our revenue.”